Polynovo Ltd (ASX: PNV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.51 billion
P/E Ratio 856.00
Dividend Yield 0.00%
Shares Outstanding 690.23 million
Earnings per share 0.003
Dividend per share N/A
Year To Date Return 29.31%
Earnings Yield 0.12%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Polynovo Ltd (ASX: PNV)
    Latest News

    A male investor erupts into a tantrum and holds his laptop above his head as though he is ready to smash it, as paper flies around him, as he expresses annoyance over so many new 52-week lows in the ASX 200 today
    Share Fallers

    Why Core Lithium, National Storage, OFX, and Polynovo shares are dropping today

    These ASX shares are having a tough time on Thursday.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

    These ASX shares are having a strong session despite the market selloff.

    Read more »

    A man packs up a box of belongings at his desk as he prepares to leave the office.
    Share Market News

    These ASX shares are being dumped from the ASX 200 index this month

    The ASX 200 doesn't have room for these shares anymore...

    Read more »

    Four people on the beach leap high into the air.
    Share Market News

    These 4 ASX shares could rocket this month: Here's why

    Fund managers will be buying up the stocks for these rapidly growing businesses, thereby pushing up the share price.

    Read more »

    doctor and nurse smiling in a hospital ward representing rising share price
    Earnings Results

    2 high-profile ASX healthcare shares lifting on blazing revenue growth

    These two companies are sporting extremely healthy revenue growth in the first half...

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    Why did ASX 300 healthcare stock Polynovo tumble 12% today?

    Polynovo had a shocker on Wednesday. Let's look at why...

    Read more »

    a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
    Opinions

    3 ASX shares I dream of owning at the right price

    These companies look incredibly appealing in my eyes. What price would it take for me to dive in?

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Share Fallers

    Why European Lithium, PEXA, PolyNovo, and Xero shares are dropping today

    These ASX shares are under pressure on Wednesday...

    Read more »

    three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
    Share Gainers

    Why Lake Resources, Platinum, Polynovo, and Volpara shares are charging higher

    These ASX shares are charging higher today...

    Read more »

    Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.
    52-Week Highs

    2 ASX All Ords shares cracking new 52-week highs on Tuesday

    Do these healthcare shares have a place in your portfolio?

    Read more »

    Five healthcare workers standing together and smiling.
    Healthcare Shares

    Bell Potter names the ASX healthcare shares to buy in 2023

    These could be the healthcare shares to buy in 2023...

    Read more »

    A happy group of workers around a table raise their arms in the air as though celebrating a work achievement. One woman is on her feet with her arm raised in the air in a fist-pumping action.
    Share Gainers

    Why Domino's, New Hope, PolyNovo, and Telstra shares are pushing higher today

    These ASX shares are having positive days...

    Read more »

    Frequently Asked Questions

    The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX  on 26 November 1998 and is headquartered in Melbourne.

    No, the company does not historically pay dividends.

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $2.19 $0.05 2.34% 1,108,859 $2.15 $2.20 $2.14
    27 Mar 2024 $2.14 $0.04 1.90% 1,793,957 $2.12 $2.22 $2.11
    26 Mar 2024 $2.10 $-0.02 -0.94% 6,338,523 $2.10 $2.12 $2.06
    25 Mar 2024 $2.12 $-0.01 -0.47% 2,646,839 $2.15 $2.16 $2.09
    22 Mar 2024 $2.13 $-0.07 -3.18% 1,118,356 $2.18 $2.19 $2.10
    21 Mar 2024 $2.20 $0.06 2.80% 2,071,350 $2.19 $2.24 $2.17
    20 Mar 2024 $2.14 $-0.05 -2.28% 1,883,237 $2.21 $2.25 $2.12
    19 Mar 2024 $2.19 $-0.16 -6.81% 2,478,168 $2.37 $2.39 $2.17
    18 Mar 2024 $2.35 $0.02 0.86% 1,183,680 $2.31 $2.36 $2.30
    15 Mar 2024 $2.33 $0.01 0.43% 2,641,536 $2.30 $2.35 $2.22
    14 Mar 2024 $2.32 $-0.17 -6.83% 2,344,276 $2.51 $2.51 $2.30
    13 Mar 2024 $2.49 $0.01 0.40% 1,851,249 $2.49 $2.52 $2.46
    12 Mar 2024 $2.48 $0.08 3.33% 3,173,551 $2.42 $2.52 $2.41
    11 Mar 2024 $2.40 $0.01 0.42% 1,306,415 $2.39 $2.44 $2.37
    08 Mar 2024 $2.39 $0.10 4.37% 3,030,795 $2.30 $2.41 $2.27
    07 Mar 2024 $2.29 $0.04 1.78% 1,609,829 $2.29 $2.30 $2.27
    06 Mar 2024 $2.25 $0.01 0.45% 1,564,337 $2.23 $2.26 $2.17
    05 Mar 2024 $2.24 $0.03 1.36% 1,531,840 $2.22 $2.25 $2.16
    04 Mar 2024 $2.21 $0.01 0.45% 2,194,703 $2.27 $2.30 $2.14
    01 Mar 2024 $2.20 $-0.08 -3.51% 2,227,886 $2.25 $2.25 $2.16
    29 Feb 2024 $2.28 $0.15 7.04% 3,585,967 $2.10 $2.28 $2.08
    28 Feb 2024 $2.13 $0.15 7.56% 6,081,790 $2.02 $2.19 $2.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2023 Robyn Elliott Buy 32,000 $38,080
    On-market trade.
    28 Jun 2023 Robyn Elliott Buy 27,000 $39,690
    On-market trade.
    08 Jun 2023 David Williams Buy 22,500 $36,000
    On-market trade.
    07 Jun 2023 David Williams Buy 14,453 $23,448
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams was appointed as a Non-executive Director on 28 February 2014 and Chairman on 13 March 2014. Mr Williams is an experienced Director and investment banker with a track record in business development as well as in mergers and acquisitions and capital raising.
    Mr Bruce Rathie Non-Executive Director Feb 2010
    Mr Rathie was appointed a Director of PolyNovo on 18 February 2010. He is an experienced Company Director with a finance and legal background. He practised as a partner in a legal firm and acted as Senior Corporate Counsel to Bell Resources Limited.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott was appointed a Director of PolyNovo on 28 October 2019. Dr Elliott is currently Global Head, Strategic Portfolio Management at CSL Behring. Dr Elliott previously held Strategic Expansion and Quality Senior Director roles within CSL, was the Managing Director at IDT Australia and commenced her career at DBL Faulding.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden was appointed a Director of PolyNovo on 4 June 2021. He has more than 20 years' experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare was appointed a Director of PolyNovo on 27 January 2016. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew ANZ (all divisions) until 2015. He served as President of Smith & Nephew's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly was appointed a Director of PolyNovo on 13 May 2020. She has more than 30 years' local and international experience. She is Vice President of the Board of the Institute of Patent and Trade Mark Attorneys of Australia on Springboard Enterprises Life Sciences Council, is a non-executive director on the board of Medical Developments International and is a member of the Australian Institute of Company Directors.
    Mr Jan-Marcel Gielen Chief Financial OfficerCompany Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan-Marcel Gielen Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 94,468,202 13.69%
    J P Morgan Nominees Australia Pty Limited 58,519,477 8.48%
    Citicorp Nominees Pty Limited 26,811,635 3.88%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    BNP Paribas Noms Pty Ltd (Drp) 12,383,050 1.79%
    Lateral Innovations Pty Ltd (Trust A/C) 10,924,103 1.58%
    National Nominees Limited 8,413,960 1.22%
    Mr Anthony Shane Kittel + Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,055,789 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 5,909,896 0.86%
    Sandhurst Trustees Ltd (Endeavor Asset Mgmt Mda A/C) 5,739,049 0.83%
    Netwealth Investments Limited (Wrap Services A/C) 4,276,587 0.62%
    Ms Simone Maree Beks 4,185,095 0.61%
    Mr Paul Gerard Brennan 4,185,095 0.61%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mr Matthew James Avery 3,631,338 0.53%
    Mrs Li-Hsien Tsai 3,292,698 0.48%
    Mr David Kenley 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff + Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Laurent Fossaert 2,929,961 0.42%
    MR CHRIS DAWBORN (HASKALI SUPER FUND A/C) 2,870,271 0.42%

    Profile

    since

    Note